CN112293748A - Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof - Google Patents
Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof Download PDFInfo
- Publication number
- CN112293748A CN112293748A CN202011199522.0A CN202011199522A CN112293748A CN 112293748 A CN112293748 A CN 112293748A CN 202011199522 A CN202011199522 A CN 202011199522A CN 112293748 A CN112293748 A CN 112293748A
- Authority
- CN
- China
- Prior art keywords
- parts
- health product
- vitamin
- astronauts
- eucommia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000208688 Eucommia Species 0.000 title claims abstract description 38
- 230000036541 health Effects 0.000 title claims abstract description 32
- 238000002360 preparation method Methods 0.000 title claims abstract description 24
- 210000000988 bone and bone Anatomy 0.000 title claims description 27
- 229910052500 inorganic mineral Inorganic materials 0.000 title claims description 24
- 239000011707 mineral Substances 0.000 title claims description 24
- 239000011575 calcium Substances 0.000 claims abstract description 45
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 45
- 235000013305 food Nutrition 0.000 claims abstract description 28
- 230000037182 bone density Effects 0.000 claims abstract description 27
- 239000002994 raw material Substances 0.000 claims abstract description 27
- 244000237330 gutta percha tree Species 0.000 claims abstract description 26
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 25
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 25
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 25
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 25
- 235000006040 Prunus persica var persica Nutrition 0.000 claims abstract description 25
- 244000144730 Amygdalus persica Species 0.000 claims abstract description 24
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 24
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 24
- 235000008434 ginseng Nutrition 0.000 claims abstract description 24
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 23
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 23
- 235000011477 liquorice Nutrition 0.000 claims abstract description 23
- 229930003316 Vitamin D Natural products 0.000 claims abstract description 22
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims abstract description 22
- 235000019166 vitamin D Nutrition 0.000 claims abstract description 22
- 239000011710 vitamin D Substances 0.000 claims abstract description 22
- 150000003710 vitamin D derivatives Chemical class 0.000 claims abstract description 22
- 229940046008 vitamin d Drugs 0.000 claims abstract description 22
- 229920002752 Konjac Polymers 0.000 claims abstract description 20
- 239000000463 material Substances 0.000 claims abstract description 20
- 241001107116 Castanospermum australe Species 0.000 claims abstract description 18
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims abstract description 18
- 235000015655 Crocus sativus Nutrition 0.000 claims abstract description 18
- 244000124209 Crocus sativus Species 0.000 claims abstract description 18
- 235000008708 Morus alba Nutrition 0.000 claims abstract description 18
- 240000000249 Morus alba Species 0.000 claims abstract description 18
- 235000021279 black bean Nutrition 0.000 claims abstract description 18
- 235000013974 saffron Nutrition 0.000 claims abstract description 18
- 239000004248 saffron Substances 0.000 claims abstract description 18
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 17
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 17
- 241000112528 Ligusticum striatum Species 0.000 claims abstract description 17
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 17
- 244000170916 Paeonia officinalis Species 0.000 claims abstract description 17
- 239000000252 konjac Substances 0.000 claims abstract description 16
- 244000247812 Amorphophallus rivieri Species 0.000 claims abstract description 15
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims abstract description 15
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 15
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 15
- 235000010485 konjac Nutrition 0.000 claims abstract description 15
- 229930003448 Vitamin K Natural products 0.000 claims abstract description 13
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000011712 vitamin K Substances 0.000 claims abstract description 13
- 235000019168 vitamin K Nutrition 0.000 claims abstract description 13
- 150000003721 vitamin K derivatives Chemical class 0.000 claims abstract description 13
- 229940046010 vitamin k Drugs 0.000 claims abstract description 13
- 235000013312 flour Nutrition 0.000 claims abstract description 11
- 241000304531 Allium macrostemon Species 0.000 claims abstract description 10
- 241000427159 Achyranthes Species 0.000 claims abstract description 7
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 31
- 235000001465 calcium Nutrition 0.000 claims description 31
- 239000000843 powder Substances 0.000 claims description 31
- 235000013336 milk Nutrition 0.000 claims description 30
- 239000008267 milk Substances 0.000 claims description 30
- 210000004080 milk Anatomy 0.000 claims description 30
- 240000004371 Panax ginseng Species 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000003814 drug Substances 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 12
- 240000002624 Mespilus germanica Species 0.000 claims description 11
- 235000017784 Mespilus germanica Nutrition 0.000 claims description 11
- 235000000560 Mimusops elengi Nutrition 0.000 claims description 11
- 235000007837 Vangueria infausta Nutrition 0.000 claims description 11
- 238000002156 mixing Methods 0.000 claims description 11
- 240000000031 Achyranthes bidentata Species 0.000 claims description 10
- 241000382455 Angelica sinensis Species 0.000 claims description 10
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 8
- 229940036811 bone meal Drugs 0.000 claims description 7
- 239000002374 bone meal Substances 0.000 claims description 7
- 240000008067 Cucumis sativus Species 0.000 claims description 6
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 235000013373 food additive Nutrition 0.000 claims description 6
- 239000002778 food additive Substances 0.000 claims description 6
- 244000183685 Citrus aurantium Species 0.000 claims description 4
- 235000007716 Citrus aurantium Nutrition 0.000 claims description 4
- 235000005087 Malus prunifolia Nutrition 0.000 claims description 4
- 244000070406 Malus silvestris Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 235000016709 nutrition Nutrition 0.000 claims description 4
- 239000003963 antioxidant agent Substances 0.000 claims description 3
- 230000003078 antioxidant effect Effects 0.000 claims description 3
- 239000003623 enhancer Substances 0.000 claims description 3
- 235000003599 food sweetener Nutrition 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 230000035764 nutrition Effects 0.000 claims description 3
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 3
- 239000003755 preservative agent Substances 0.000 claims description 3
- 230000002335 preservative effect Effects 0.000 claims description 3
- 239000003765 sweetening agent Substances 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 2
- 238000001914 filtration Methods 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000006072 paste Substances 0.000 claims description 2
- 239000006187 pill Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 241000238557 Decapoda Species 0.000 claims 1
- 244000000231 Sesamum indicum Species 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 22
- 235000013399 edible fruits Nutrition 0.000 abstract description 16
- 244000241838 Lycium barbarum Species 0.000 abstract description 13
- 235000015459 Lycium barbarum Nutrition 0.000 abstract description 13
- 235000015468 Lycium chinense Nutrition 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 10
- 210000004369 blood Anatomy 0.000 abstract description 10
- 241000405414 Rehmannia Species 0.000 abstract description 8
- 229940069978 calcium supplement Drugs 0.000 abstract description 8
- 208000031971 Yin Deficiency Diseases 0.000 abstract description 6
- 230000008506 pathogenesis Effects 0.000 abstract description 3
- 230000002440 hepatic effect Effects 0.000 abstract description 2
- 241000190633 Cordyceps Species 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 37
- 235000010755 mineral Nutrition 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 235000002639 sodium chloride Nutrition 0.000 description 18
- 210000003734 kidney Anatomy 0.000 description 11
- 206010065687 Bone loss Diseases 0.000 description 10
- 210000004185 liver Anatomy 0.000 description 9
- 241000700159 Rattus Species 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 244000040738 Sesamum orientale Species 0.000 description 7
- 241000143060 Americamysis bahia Species 0.000 description 6
- 244000042037 Malus x micromalus Species 0.000 description 5
- 235000018960 Malus x micromalus Nutrition 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000004072 lung Anatomy 0.000 description 5
- 239000000725 suspension Substances 0.000 description 5
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 4
- ZQBZAOZWBKABNC-UHFFFAOYSA-N [P].[Ca] Chemical compound [P].[Ca] ZQBZAOZWBKABNC-UHFFFAOYSA-N 0.000 description 4
- 235000013361 beverage Nutrition 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000005486 microgravity Effects 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 208000000913 Kidney Calculi Diseases 0.000 description 3
- 206010029148 Nephrolithiasis Diseases 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 3
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 230000004438 eyesight Effects 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 229940116269 uric acid Drugs 0.000 description 3
- 230000002485 urinary effect Effects 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 235000006751 Platycodon Nutrition 0.000 description 2
- 241000700157 Rattus norvegicus Species 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000001174 ascending effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000004097 bone metabolism Effects 0.000 description 2
- 235000021375 calcium rich food Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 230000011164 ossification Effects 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229930189914 platycodon Natural products 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000473 propyl gallate Substances 0.000 description 2
- 235000010388 propyl gallate Nutrition 0.000 description 2
- 229940075579 propyl gallate Drugs 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 210000000582 semen Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000001502 supplementing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- SERLAGPUMNYUCK-DCUALPFSSA-N 1-O-alpha-D-glucopyranosyl-D-mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SERLAGPUMNYUCK-DCUALPFSSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- MRBKEAMVRSLQPH-UHFFFAOYSA-N 3-tert-butyl-4-hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1 MRBKEAMVRSLQPH-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 206010002482 Angiosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 208000010392 Bone Fractures Diseases 0.000 description 1
- 208000006386 Bone Resorption Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- BCZXFFBUYPCTSJ-UHFFFAOYSA-L Calcium propionate Chemical compound [Ca+2].CCC([O-])=O.CCC([O-])=O BCZXFFBUYPCTSJ-UHFFFAOYSA-L 0.000 description 1
- 102000011632 Caseins Human genes 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000009083 Fructus psoraleae extract Substances 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 241000096284 Gynochthodes officinalis Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- IMQLKJBTEOYOSI-GPIVLXJGSA-N Inositol-hexakisphosphate Chemical compound OP(O)(=O)O[C@H]1[C@H](OP(O)(O)=O)[C@@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@H](OP(O)(O)=O)[C@@H]1OP(O)(O)=O IMQLKJBTEOYOSI-GPIVLXJGSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- 102000004067 Osteocalcin Human genes 0.000 description 1
- 108090000573 Osteocalcin Proteins 0.000 description 1
- 206010031264 Osteonecrosis Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- IMQLKJBTEOYOSI-UHFFFAOYSA-N Phytic acid Natural products OP(O)(=O)OC1C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C(OP(O)(O)=O)C1OP(O)(O)=O IMQLKJBTEOYOSI-UHFFFAOYSA-N 0.000 description 1
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 1
- 235000011613 Pinus brutia Nutrition 0.000 description 1
- 241000018646 Pinus brutia Species 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- 240000005809 Prunus persica Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 244000275012 Sesbania cannabina Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000009470 Theobroma cacao Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000008326 Trichosanthes anguina Nutrition 0.000 description 1
- 244000078912 Trichosanthes cucumerina Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 108091005605 Vitamin K-dependent proteins Proteins 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000002805 bone matrix Anatomy 0.000 description 1
- 230000010478 bone regeneration Effects 0.000 description 1
- 230000010072 bone remodeling Effects 0.000 description 1
- 230000024279 bone resorption Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 239000004330 calcium propionate Substances 0.000 description 1
- 235000010331 calcium propionate Nutrition 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000021523 carboxylation Effects 0.000 description 1
- 238000006473 carboxylation reaction Methods 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 230000027288 circadian rhythm Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002876 effect on osteoporosis Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000020696 epimedium extract Nutrition 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000004225 ferrous lactate Substances 0.000 description 1
- 235000013925 ferrous lactate Nutrition 0.000 description 1
- 229940037907 ferrous lactate Drugs 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- UHBYWPGGCSDKFX-VKHMYHEASA-N gamma-carboxy-L-glutamic acid Chemical compound OC(=O)[C@@H](N)CC(C(O)=O)C(O)=O UHBYWPGGCSDKFX-VKHMYHEASA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- -1 idacin Chemical compound 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000002085 irritant Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000905 isomalt Substances 0.000 description 1
- 235000010439 isomalt Nutrition 0.000 description 1
- HPIGCVXMBGOWTF-UHFFFAOYSA-N isomaltol Natural products CC(=O)C=1OC=CC=1O HPIGCVXMBGOWTF-UHFFFAOYSA-N 0.000 description 1
- 235000019823 konjac gum Nutrition 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229930189775 mogroside Natural products 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 210000000963 osteoblast Anatomy 0.000 description 1
- 210000002997 osteoclast Anatomy 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000002949 phytic acid Nutrition 0.000 description 1
- 239000000467 phytic acid Substances 0.000 description 1
- 229940068041 phytic acid Drugs 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229960003885 sodium benzoate Drugs 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229940080237 sodium caseinate Drugs 0.000 description 1
- JXKPEJDQGNYQSM-UHFFFAOYSA-M sodium propionate Chemical compound [Na+].CCC([O-])=O JXKPEJDQGNYQSM-UHFFFAOYSA-M 0.000 description 1
- 239000004324 sodium propionate Substances 0.000 description 1
- 235000010334 sodium propionate Nutrition 0.000 description 1
- 229960003212 sodium propionate Drugs 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001694 thigh bone Anatomy 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 229940074777 tripotassium glycyrrhizinate Drugs 0.000 description 1
- ZXHXYXSTAYNRLQ-DWJAGBRCSA-K tripotassium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4, Chemical compound [K+].[K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O ZXHXYXSTAYNRLQ-DWJAGBRCSA-K 0.000 description 1
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8962—Allium, e.g. garden onion, leek, garlic or chives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a eucommia health product capable of improving the bone density of astronauts and a preparation method thereof, wherein the eucommia health product comprises the following raw materials: 1-7.5 parts of eucommia ulmoides, 1-15 parts of high-calcium food materials, 0.5-5 parts of mulberry leaves, 0.3-3 parts of ginseng and 0.1-10 parts of konjac flour; fructus Lycii and Cordyceps militarisAt least one of black beans, 1-6 parts of cordyceps militaris, 1-6 parts of wolfberry fruit and 10-30 parts of black beans; peach kernel, saffron, safflower, angelica, red peony root, rehmannia root or achyranthes root, 0.5-5 parts of peach kernel, 0.1-1 parts of saffron, 0.3-3 parts of safflower, 0.6-6 parts of angelica, 0.6-6 parts of red peony root, 1-10 parts of rehmannia root and 0.5-5 parts of achyranthes root; orange peel, at least one of fingered citron, allium macrostemon, platycodon grandiflorum, ligusticum wallichii or fructus aurantii, 0.3-3 parts of orange peel, 0.3-3 parts of fingered citron, 0.5-5 parts of allium macrostemon, 0.3-3 parts of platycodon grandiflorum, 0.3-3 parts of ligusticum wallichii, 0.3-3 parts of fructus aurantii and 0.2-2 parts of liquorice; at least one of vitamin D or vitamin K, vitamin D (1-50) x 10‑6Part of vitamin K (1-80) x 10‑6And (4) portions are obtained. The invention ensures the edible safety, reduces the risk caused by excessive calcium supplement, gives consideration to the pathogenesis of hepatic and renal yin deficiency, qi stagnation and blood stasis of astronauts, and obviously improves the bone density.
Description
Technical Field
The invention relates to the technical field of health products, belongs to the field of functional space food development, and particularly relates to an eucommia ulmoides health product capable of improving the bone density of astronauts and a preparation method thereof.
Background
When the astronaut executes the space mission, the astronaut can bring a lot of adverse effects to the physiological system of the astronaut due to the influence of environmental factors such as special environment weightlessness, noise, vibration, radiation, circadian rhythm change, narrow space and the like. 1-2% of bone calcium is mobilized and lost by astronauts every month on average; even if physical exercise is performed for 2-3 hours every day, bone calcium is still lost at the rate of 0.4% per month, the bone mass is reduced along with the prolonging of the space retention time, and the bone calcium still has irreversibility after returning to the ground, which can greatly hinder the rapid development of the aerospace industry. Therefore, effective prevention and treatment of bone loss in space environment are always important subjects for aerospace medical research.
There have been many attempts to combat bone loss caused by microgravity in space flight. The current major route of bone loss in the foreign fight space environment is to perform appropriate physical exercise, resistance training and to perform pharmacological interventions. Clinical practice proves that the intervention has poor prevention and treatment effects on bone loss caused by space environment, and serious side effects are accompanied after a large amount of medicine is taken. Therefore, the search for a nontoxic and significant health-care food with dual functions of bone loss prevention and health care becomes one of important ways for solving the problem of the adaptability of astronauts to microgravity environments.
Bone remodeling continues due to the synthesis of bone matrix by osteoblasts and resorption of bone by osteoclasts. Most of the drugs for osteoporosis mainly inhibit bone resorption and do not promote bone formation, so that it is difficult to promote bone regeneration in a space environment. Although some of the currently available drugs can treat bone loss to some extent, corresponding measures are still required to minimize potential side effects on other organs during treatment. Natural products of plant origin offer the potential for the treatment of bone-related diseases and studies conducted under different preclinical and clinical conditions can demonstrate the effectiveness of natural products in treating bone loss. The search and development of bone loss prevention medicines and health-care foods from natural products are an important direction for preventing the bone loss of astronauts in space environment.
Under the comprehensive effects of space microgravity, radiation, narrow isolation environment and the like, a series of physiological function changes of a human body can occur. Researchers believe that blood stasis and kidney deficiency can occur in both long-term retention and simulated weightlessness in an aerospace microgravity environment. The fatigue of the metabolism is analyzed by using the theory of traditional Chinese medicine, and the syndrome is distinguished that the early stage of the spaceflight is accompanied by syncope, abnormal ascending and descending and longer spaceflight time, the symptom of deficiency-excess is presented, and the syndrome is distinguished that liver-kidney yin deficiency is combined with qi stagnation and blood stasis. This provides theoretical guidance for finding astronaut food from natural products.
Disclosure of Invention
Aiming at the defects of the prior art, the invention provides the eucommia health-care product capable of improving the bone density of astronauts and the preparation method thereof, so that the edible safety is ensured, the risk caused by excessive calcium supplement is reduced, the pathogenesis of liver-kidney yin deficiency, qi stagnation and blood stasis of the astronauts is considered, and the effect of improving the bone density is obvious.
The invention is realized by the following technical scheme:
the eucommia health-care product capable of improving the bone density of astronauts is provided, and comprises the following raw material components in parts by weight:
1-7.5 parts of eucommia ulmoides, 1-15 parts of high-calcium food materials, 0.5-5 parts of mulberry leaves, 0.3-3 parts of ginseng and 0.1-10 parts of konjac flour;
the feed also comprises at least one of medlar, cordyceps militaris and black bean, 1-6 parts of cordyceps militaris, 1-6 parts of medlar and 10-30 parts of black bean;
the medicine also comprises at least one of peach kernel, saffron, safflower, angelica, red peony root, radix rehmanniae or achyranthes bidentata, 0.5-5 parts of peach kernel, 0.1-1 part of saffron, 0.3-3 parts of safflower, 0.6-6 parts of angelica, 0.6-6 parts of red peony root, 1-10 parts of radix rehmanniae and 0.5-5 parts of achyranthes bidentata;
the food is characterized by also comprising at least one of orange peel, fingered citron, allium macrostemon, platycodon grandiflorum, ligusticum wallichii or fructus aurantii, 0.3-3 parts of orange peel, 0.3-3 parts of fingered citron, 0.5-5 parts of allium macrostemon, 0.3-3 parts of platycodon grandiflorum, 0.3-3 parts of ligusticum wallichii, 0.3-3 parts of fructus aurantii and 0.2-2 parts of liquorice;
further comprises at least one of vitamin D or vitamin K, vitamin D (1-50) x 10-6Part of vitamin K (1-80) x 10-6And (4) portions are obtained.
Eucommia bark, slightly pungent, warm in nature; entering liver and kidney meridians; tonify liver and kidney, strengthen tendons and bones; belongs to the top grade of traditional Chinese medicine. The root cause of the bad muscles and bones is the bad liver and kidney, and it has no effect to supplement calcium without tonifying liver and kidney.
Mulberry leaf, sweet, bitter and cold. Enter lung and liver meridians, dispel wind-heat, clear lung-heat, moisten dryness, clear liver and improve vision. The mulberry leaves can dredge the ascending and descending functions of lung qi. The mulberry leaf has rich calcium content: 1000-3000 mg/100g, which is far higher than common calcium-rich food such as milk, bean products, cheese and the like.
Ginseng is sweet, slightly bitter and warm. The channels of spleen, lung, heart and kidney belong to the homologous varieties of medicine and food, and have the effects of greatly reinforcing primordial qi, recovering pulse, relieving depletion, reinforcing spleen, benefiting lung and strengthening bones and muscles. Qi is the commander of blood, blood is the mother of qi, qi circulation is blood circulation, qi stagnation is blood stasis, and ginseng tonifies primordial qi greatly, dredges blood vessels and effectively improves symptoms of qi stagnation and blood stasis of astronauts.
The sticky property of the konjac flour endows the food with a gelatinous characteristic, so that the food is convenient for astronauts to eat in outer space. The compound of the konjac flour and the mulberry leaf powder can promote the normal growth of the thighbone of a mouse, increase the storage amount of calcium in the bone and improve the quality of the bone.
Fructus Lycii, Cordyceps militaris, and semen Sojae Atricolor can be used for tonifying kidney yin and liver yin.
The medlar has neutral nature and sweet taste, and has the functions of tonifying the kidney and nourishing the liver, replenishing vital essence and improving eyesight, strengthening bones and muscles, removing lumbago, prolonging life and the like after being taken for a long time. The book Ben Cao Jing Shu also says: medlar is the essential herb for fatigue, internal heat and invigoration due to deficiency of liver and kidney yin, and seven or eight of ten for the old with yin deficiency, so it is the top grade good for replenishing vital essence and improving eyesight to eat. "
Cordyceps militaris is warm in nature, sweet in taste, enters kidney and lung meridians, and is a rare medicinal material for balancing yin and yang.
Black bean, Li Shizhen, is recorded in Ben Cao gang mu (compendium of materia Medica); if the black beans are eaten frequently, the diseases can be cured. Used for treating kidney deficiency, yin deficiency, diabetes, polydipsia and frequent micturition; deficiency of liver-yin and kidney-yin, dizziness, blurred vision, or early white beard and hair.
Peach kernel, saffron, safflower, Chinese angelica root, red peony root, dried rehmannia root and achyranthes root are used for promoting blood circulation and removing blood stasis.
Tangerine peel, fingered citron, longstamen onion bulb, platycodon grandiflorum, ligusticum wallichii and bitter orange are used for promoting qi circulation.
Licorice root: harmonize the drugs.
Vitamin D promotes the absorption of calcium by the intestinal tract.
Vitamin K is an accessory factor formed by gamma-carboxyglutamic acid in protein, and the vitamin K in vivo mainly influences the carboxylation of bone-derived vitamin K-dependent protein osteocalcin so as to promote the deposition of bone mineral salt.
Further, the high calcium food material comprises one or more of milk mineral salt, bone meal, milk powder, sesame paste, dried small shrimps, crab apple and cucumber seed.
High-calcium food material: milk powder, sesame paste, dried small shrimps, cucumber seeds, crab apple, bone meal, milk mineral salt and the like. The calcium-rich food has balanced and comprehensive nutritional structure, is the highest-quality food source of calcium, and has lower possibility of causing calculus and angiosclerosis.
The content of calcium in milk powder is 1797mg/100 g.
The sesame paste has a calcium content of 1057mg/100g, and is a calcium king in pastes.
The calcium content of the dried small shrimps is up to 991mg/100g, and the dried small shrimps are the calcium king in aquatic products.
The calcium content of cucumber seeds is as follows: 89.9mg/100g, is the calcium king in the dry fruit. The snake gourd seed calcium supplement and bone strengthening health care product has the effects of supplementing calcium, setting a broken bone, strengthening bones and building a body, has rich calcium content and proper calcium-phosphorus proportion, is easy to be absorbed by a human body, has the effects of repairing bone damage necrosis and strain, and has a good improving effect on osteoporosis and bone necrosis by supplementing calcium and building a body all the time.
The malus micromalus makino contains various trace elements beneficial to human bodies, wherein the malus micromalus makino contains 66.59mg/100g of calcium, 2.16mg/100g of iron and 0.54mg/100g of zinc, the calcium is positioned at the head of fruits, and the malus micromalus makino is called as the fruit-in-calcium king.
The bone meal contains 20% of calcium and 10% of phosphorus, is a multipurpose bovine bone meal, has a calcium-phosphorus ratio close to that of a human body, contains a certain protein component, has an obvious calcium supplement effect, and has a higher absorption rate than that of a common calcium tablet.
A milk mineral salt is a new resource food, which is prepared from whey as raw material by removing protein and lactose. The calcium content is 23-28%, the phosphorus content is 10-14%, and the calcium-phosphorus composite material is natural, safe and non-irritant and can be effectively absorbed and utilized by a human body; the calcium supplement agent is close to the composition of human skeleton teeth, and has reasonable calcium-phosphorus ratio, so that the calcium supplement effect is better; and the calcium supplement effect is not reversed, and the increased bone density is still maintained even after the milk mineral salt supplement is stopped for three years.
Further, the eucommia bark comprises one or more of eucommia leaf, eucommia male flower and eucommia bark.
A preparation method of the eucommia ulmoides health product capable of improving the bone mineral density of astronauts is characterized in that high-calcium food materials are ground into powder and then are mixed with the rest raw materials after being ground into powder.
A preparation method of the eucommia ulmoides health product capable of improving the bone density of astronauts comprises the steps of extracting the raw materials except the high-calcium food materials, filtering to obtain a mixed extracting solution, and mixing and matching the mixed extracting solution with the high-calcium food materials.
A preparation method of the eucommia health product capable of improving the bone density of astronauts comprises the steps of extracting eucommia in component raw materials to obtain an extracting solution, concentrating, drying and crushing the eucommia fine powder, grinding mulberry leaves, ginseng, medlar, cordyceps militaris, black beans, peach kernels, saffron, safflower, angelica sinensis, red paeony roots, radix rehmanniae, achyranthes roots, orange peels, fingered citron, allium macrostemon, platycodon grandiflorum, ligusticum wallichii, bitter orange and liquorice, and matching the ground eucommia fine powder with crushed high-calcium food materials.
Further, in the process of compatibility, food additives are added, wherein the food additives comprise at least one of acidity regulator, sweetener, preservative, antioxidant, excipient and nutrition enhancer.
Wherein: the acidity regulator is selected from any one of citric acid, malic acid, tartaric acid, adipic acid, sodium carbonate, lactic acid, fumaric acid, succinic acid, citrate, and fruit vinegar;
the sweetener is at least one of white sugar, fructose, maltitol, isomalt, trehalose, erythritol, idacin, xylitol, fructo-oligosaccharide, sorbitol, stevioside, sucralose, mogroside, glucose, sucrose, maltose, lactose, sugar alcohol, licorice, disodium glycyrrhizinate, tripotassium glycyrrhizinate, trisodium glycyrrhizinate, aspartame and acesulfame potassium.
The preservative is selected from any one of benzoic acid, sodium benzoate, sorbic acid, potassium sorbate, sodium propionate, nisin, calcium propionate and dehydroacetic acid;
the antioxidant is selected from any one of ascorbic acid, butyl hydroxy anisol, tea polyphenols, propyl gallate, phytic acid, dibutyl hydroxy toluene and propyl gallate;
the excipient is at least one selected from starch, maltodextrin, xanthan gum, carrageenan, konjac gum, konjac flour, sodium carboxymethylcellulose, sesbania gum, tamarind seed gum, gelatin, acacia, sodium caseinate, cyclodextrin, pectin, soybean milk powder, cocoa powder and magnesium stearate;
the nutrition enhancer is selected from: at least one of trace elements, vitamins, calcium lactate, ferrous lactate, and potassium gluconate.
Furthermore, the dosage form of the eucommia health care product prepared by compatibility is capsules, tablets, granules, paste, pills or oral liquid.
Compared with the prior art, the invention has the beneficial effects that:
based on eucommia ulmoides and high-calcium food materials, auxiliary medicinal materials are added. The compatibility principle is as follows: eucommia bark/eucommia leaf/eucommia male flower is used as a monarch drug, the raw material with high calcium content is used as a ministerial drug, the other materials (except liquorice) are used as adjuvant drugs, and the liquorice is used as a conductant drug. The edible safety is ensured, the risk caused by excessive calcium supplement is reduced, the pathogenesis of hepatic and renal yin deficiency, qi stagnation and blood stasis of astronauts is considered, and the effect of improving the bone density is obvious. Other food raw materials can be added on the basis of the formula to achieve similar effects or purposes.
Detailed Description
In order to clearly illustrate the technical features of the present solution, the present solution is explained below by way of specific embodiments.
Example 1:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 6g of male eucommia ulmoides flower, 10g of cucumber seed, 5g of milk mineral salt, 5g of peach kernel, 0.6g of saffron, 1g of Chinese angelica, 1g of orange peel, 3g of fingered citron, 3g of frosted mulberry leaf, 3g of platycodon grandiflorum, 3g of ginseng, 1g of liquorice, 6g of konjaku flour, 25g of black bean, 1g of cordyceps militaris, 6g of wolfberry fruit and 5 mu g of vitamin D.
The preparation method comprises the following steps: preparing raw materials according to the above quality, extracting eucommia male flowers to obtain an extracting solution, concentrating, drying and crushing, crushing cucumber seeds, peach kernels, saffron, angelica sinensis, orange peel, ginseng, fingered citron, frosted mulberry leaves, platycodon grandiflorum, liquorice, cordyceps militaris, wolfberry fruits and black beans, adding konjac powder, milk mineral salt and vitamin D, uniformly mixing, granulating and preparing the solid beverage.
Example 2:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 5g of eucommia male flower, 15g of milk powder, 5g of sesame paste, 3g of peach kernel, 0.8g of saffron, 3g of Chinese angelica, 2g of orange peel, 2g of fingered citron, 4g of frost mulberry leaf, 2g of platycodon grandiflorum, 2g of ginseng, 1.5g of liquorice, 5g of konjaku flour, 20g of black bean, 2g of cordyceps militaris, 6g of wolfberry fruit and 25 mu g of vitamin D.
The preparation method comprises the following steps: preparing raw materials according to the above quality, crushing eucommia male flower, peach kernel, saffron, angelica, orange peel, ginseng, fingered citron, frosted mulberry leaf, platycodon grandiflorum, liquorice, cordyceps militaris, medlar and black bean, adding konjac powder, milk powder, sesame paste and vitamin D, uniformly mixing, and preparing the tablet candy.
Example 3:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 4g of eucommia male flower, 15g of dried small shrimps, 2g of peach kernel, 1g of saffron, 2g of Chinese angelica, 3g of orange peel, 1g of fingered citron, 5g of frosted mulberry leaf, 1g of platycodon root, 1g of ginseng, 2g of liquorice, 4g of konjaku flour, 15g of black bean, 3g of cordyceps militaris, 6g of medlar and 10 mu g of vitamin D.
The preparation method comprises the following steps: preparing raw materials according to the above quality, extracting eucommia male flowers to obtain an extracting solution, concentrating, drying, crushing dried small shrimps, peach kernels, saffron, angelica sinensis, orange peel, ginseng, fingered citron, frosted mulberry leaves, platycodon grandiflorum, liquorice, cordyceps militaris, wolfberry fruits and black beans, adding konjac powder, milk mineral salt and vitamin D, uniformly mixing, granulating and preparing the solid beverage.
Example 4:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 6g of eucommia ulmoides, 10g of crab apple, 5g of bone meal, 4g of peach kernel, 2g of safflower, 4g of angelica, 4g of red peony root, 10g of radix rehmanniae, 1g of ligusticum wallichii, 3g of fructus aurantii, 1g of platycodon grandiflorum, 3g of ginseng, 3g of achyranthes bidentata, 2g of liquorice, 4g of cordyceps militaris, 6g of wolfberry fruit, 20 mu g of vitamin D and 50 mu g of vitamin K.
The preparation method comprises the following steps: preparing raw materials according to the above quality, extracting eucommia ulmoides, peach kernel, safflower, angelica, red paeony root, rehmannia root, ligusticum wallichii, fructus aurantii, platycodon grandiflorum, ginseng, achyranthes bidentata, cordyceps militaris, wolfberry fruit and liquorice to obtain an extracting solution, concentrating, drying and crushing; pulverizing Malus micromalus makino; adding Malus micromalus makino powder, bone meal, vitamin D, vitamin K and food additive, mixing, granulating, and tabletting to obtain hard capsule.
Example 5:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: preparing raw materials according to the mass, 4g of eucommia leaves, 10g of milk powder, 4g of milk mineral salt, 1g of peach kernels, 2.5g of safflower, 5g of angelica, 5g of red peony roots, 8g of dried rehmannia roots, 2g of ligusticum wallichii, 2g of fructus aurantii, 2g of platycodon grandiflorum, 2g of ginseng, 4g of achyranthes roots, 1.5g of liquorice, 5g of cordyceps militaris, 5g of wolfberry fruits and 30 mu g of vitamin K.
The preparation method comprises the following steps: extracting folium Eucommiae, semen Persicae, flos Carthami, radix Angelicae sinensis, radix Paeoniae Rubra, radix rehmanniae, rhizoma Chuanxiong, fructus Aurantii, radix Platycodonis, radix Ginseng, radix Achyranthis bidentatae, Cordyceps militaris, fructus Lycii, and radix Glycyrrhizae to obtain extractive solution, concentrating, drying, and pulverizing; adding milk powder, milk mineral salt, vitamin K, and food additive, mixing, and tabletting to obtain soft capsule.
Example 6:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 3g of eucommia ulmoides, 8g of milk powder, 3g of milk mineral salt, 5g of peach kernel, 3g of safflower, 6g of angelica, 6g of red peony root, 6g of radix rehmanniae, 3g of ligusticum wallichii, 1g of fructus aurantii, 3g of platycodon grandiflorum, 1g of ginseng, 5g of achyranthes bidentata, 1g of liquorice, 6g of cordyceps militaris, 4g of wolfberry fruit, 8g of konjac powder and 30 mu g of vitamin D.
The preparation method comprises the following steps: preparing the raw materials according to the mass, extracting eucommia ulmoides, peach kernel, safflower, angelica, red paeony root, rehmannia root, ligusticum wallichii, fructus aurantii, platycodon grandiflorum, ginseng, achyranthes bidentata, cordyceps militaris, wolfberry fruit and liquorice to obtain an extracting solution, and adding milk powder, milk mineral salt, konjac powder and vitamin D to be completely dissolved to obtain the liquid beverage.
Example 7:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 15g of milk powder, 5g of sesame paste, 3g of peach kernel, 0.8g of saffron, 3g of Chinese angelica, 2g of orange peel, 2g of fingered citron, 4g of frosted mulberry leaf, 2g of platycodon root, 2g of ginseng, 1.5g of liquorice, 5g of konjaku flour, 20g of black bean, 2g of cordyceps militaris, 6g of wolfberry fruit and 25 mu g of vitamin D.
The preparation method comprises the following steps: preparing the raw materials according to the mass, crushing peach kernels, saffron, angelica sinensis, orange peel, ginseng, fingered citron, frosted mulberry leaves, platycodon grandiflorum, liquorice, cordyceps militaris, wolfberry fruits and black beans, adding konjac powder, milk powder, sesame paste and vitamin D, uniformly mixing, and preparing the tablet candy.
Example 8:
a eucommia health product capable of improving the bone density of astronauts comprises the following raw material components in parts by weight: 8g of milk powder, 3g of milk mineral salt, 5g of peach kernel, 3g of safflower, 6g of angelica, 6g of red peony root, 6g of radix rehmanniae, 3g of ligusticum wallichii, 1g of fructus aurantii, 3g of platycodon grandiflorum, 1g of ginseng, 5g of achyranthes bidentata, 1g of liquorice, 6g of cordyceps militaris, 4g of wolfberry fruit, 8g of konjac powder and 30 mu g of vitamin D.
The preparation method comprises the following steps: preparing the raw materials according to the mass, extracting peach kernel, safflower, angelica, red peony root, rehmannia root, ligusticum wallichii, bitter orange, platycodon grandiflorum, ginseng, achyranthes root, cordyceps militaris, medlar and liquorice to obtain an extracting solution, and adding milk powder, milk mineral salt, konjac powder and vitamin D to be completely dissolved to obtain the liquid beverage.
The above 8 examples were validated for efficacy:
the rat tail suspension can better simulate the body fluid head distribution and the load shedding phenomenon of the bearing bone during weightlessness, and is a recognized animal model for simulating the bone loss in space at present. The influence of tail suspension simulated weightlessness on rat bone metabolism is mainly shown in that the reduction of bone formation capability is consistent with the change of space flight bone metabolism, and the model is also a NASA classic model.
Experiment one:
90 male Wistar rats of 5 weeks of age were selected and randomly divided into 13 groups:
free-moving group, suspension group, examples 1-6 groups, control group, each group was 10.
Wherein:
the free activity group only carries out single-cage feeding, and the rat can freely move;
the rats in the other groups were suspended with their tails suspended and their hind limbs off the ground for 21 days, and the stomach was perfused with 0.15g/kg of sample per day. And detecting the content of bone minerals and the elastic deflection.
Experiment two:
90 male Wistar rats of 5 weeks of age were selected and randomly divided into 13 groups:
free-moving group, suspension group, examples 1-6 groups, control group, each group was 10.
Intragastric administration of stone-inducing agent (containing 0.75% ethylene glycol, 0.75% ammonium chloride, 1 mL/time, 3 times/d) was given to each group;
wherein:
the free activity group only carries out single-cage feeding, and the rat can freely move;
the rats in the other groups were suspended with their tails suspended and their hind limbs off the ground for 21 days, and the stomach was perfused with 0.15g/kg of sample per day. Detecting the oxalic acid content and the calcium content of urine, and comparing the probability of forming kidney stones.
Control group: the preparation method comprises the following steps of taking 21g of pine polyphenol extract as a main component, and mixing 12g of morinda officinalis extract, 12g of rhizoma drynariae extract, 12g of epimedium extract, 8g of prepared rehmannia root extract, 12g of fructus psoraleae extract, 3g of eucommia ulmoides extract, 4g of radix achyranthis bidentatae extract, 5g of astragalus mongholicus extract, 5g of polygonum multiflorum extract, 1g of radix puerariae extract and 1g of salvia miltiorrhiza extract uniformly.
The experiment for increasing bone density by suspending the tail of the rat is shown in the following table:
group of | Bone mineral salt content | Elastic deflection (mm) |
Free moving group | 0.528±0.008 | 0.43±0.15 |
Suspension set | 0.440±0.008 | 0.33±0.14 |
Control group | 0.469±0.003 | 0.36±0.15 |
Example 1 | 0.483±0.002 | 0.39±0.16 |
Example 2 | 0.490±0.005 | 0.40±0.11 |
Example 3 | 0.475±0.004 | 0.38±0.17 |
Example 4 | 0.486±0.005 | 0.39±0.18 |
Example 5 | 0.493±0.006 | 0.40±0.14 |
Example 6 | 0.501±0.004 | 0.40±0.15 |
Example 7 | 0.470±0.004 | 0.36±0.14 |
Example 8 | 0.469±0.003 | 0.37±0.16 |
And (4) conclusion:
1. the groups of the embodiments have the obvious effect of improving the content of bone mineral salt and the elastic flexibility.
2. The effects of improving the bone mineral salt content and the elastic deflection of the groups of examples 1-6 are better than those of the control group.
3. The efficacy of the groups 7 and 8 in increasing the bone mineral salt content and the elastic deflection is equivalent to that of the control group. The example 7 group is lower than the example 2 group, and the example 8 group is lower than the example 6 group, which shows that the eucommia bark plays a role in multiplying the efficacies.
The results of the experiment for reducing the risk of renal calculus by suspending the tail of the rat are shown in the following table:
and (4) conclusion:
1. the groups of examples had significant efficacy in reducing uric acid and urinary calcium levels, with lower levels indicating a lower risk of kidney stone formation.
2. The effect of reducing the uric acid content and the urinary calcium content of the groups of examples 1-6 is better than that of the control group.
3. The efficacy of reducing uric acid content and urinary calcium content in the groups of examples 7 and 8 is equivalent to that of the control group. The example 2 group is lower than the example 7 group, and the example 6 group is lower than the example 8 group, which shows that the eucommia bark plays a role in multiplying the efficacies.
Of course, the above description is not limited to the above examples, and the undescribed technical features of the present invention can be implemented by or using the prior art, and will not be described herein again; the above embodiments are merely for illustrating the technical solutions of the present invention and not for limiting the present invention, and the present invention has been described in detail with reference to the preferred embodiments, and those skilled in the art should understand that changes, modifications, additions or substitutions which are made by those skilled in the art within the spirit of the present invention are also within the scope of the claims of the present invention.
Claims (9)
1. A eucommia bark health product capable of improving the bone mineral density of astronauts is characterized in that: comprises the following raw material components in parts by weight:
1-7.5 parts of eucommia ulmoides, 1-15 parts of high-calcium food materials, 0.5-5 parts of mulberry leaves, 0.3-3 parts of ginseng and 0.1-10 parts of konjac flour;
the feed also comprises at least one of medlar, cordyceps militaris and black bean, 1-6 parts of cordyceps militaris, 1-6 parts of medlar and 10-30 parts of black bean;
the medicine also comprises at least one of peach kernel, saffron, safflower, angelica, red peony root, radix rehmanniae or achyranthes bidentata, 0.5-5 parts of peach kernel, 0.1-1 part of saffron, 0.3-3 parts of safflower, 0.6-6 parts of angelica, 0.6-6 parts of red peony root, 1-10 parts of radix rehmanniae and 0.5-5 parts of achyranthes bidentata;
the food is characterized by also comprising at least one of orange peel, fingered citron, allium macrostemon, platycodon grandiflorum, ligusticum wallichii or fructus aurantii, 0.3-3 parts of orange peel, 0.3-3 parts of fingered citron, 0.5-5 parts of allium macrostemon, 0.3-3 parts of platycodon grandiflorum, 0.3-3 parts of ligusticum wallichii, 0.3-3 parts of fructus aurantii and 0.2-2 parts of liquorice;
further comprises at least one of vitamin D or vitamin K, vitamin D (1-50) x 10-6Part of vitamin K (1-80) x 10-6And (4) portions are obtained.
2. The eucommia ulmoides oliv health product for increasing bone density of astronauts as claimed in claim 1, wherein: 4.5-7.5 parts of eucommia bark, 5-15 parts of high-calcium food material, 2-3 parts of mulberry leaf, 1-3 parts of ginseng, 1-9 parts of konjac flour, 3-5 parts of peach kernel, 0.5-1 part of saffron, 1-3 parts of safflower, 3-6 parts of angelica, 3-6 parts of red peony root, 5-10 parts of radix rehmanniae, 2-5 parts of achyranthes root, 1-3 parts of orange peel, 1-3 parts of fingered citron, 3-5 parts of allium macrostemon, 1-3 parts of platycodon grandiflorum, 1-3 parts of ligusticum wallichii, 1-3 parts of fructus aurantii, 1-2 parts of liquorice, and vitamin D (10-30) x 10-6Part of vitamin K (10-60) x 10-6And (4) portions are obtained.
3. The eucommia ulmoides oliv health product for increasing bone density of astronauts as claimed in claim 1 or 2, wherein: the high calcium food material comprises one or more of milk mineral salt, bone meal, milk powder, sesame paste, dried small shrimp, crab apple and cucumber seed.
4. The eucommia ulmoides oliv health product for increasing bone density of astronauts as claimed in claim 1 or 2, wherein: the Eucommiae cortex comprises one or more of folium Eucommiae, male flower of Eucommiae cortex and cortex Eucommiae.
5. The preparation method of the eucommia ulmoides health product capable of improving the bone density of astronauts as claimed in claim 1, wherein the preparation method comprises the following steps: grinding high calcium food material, mixing with the rest materials, and mixing.
6. The preparation method of the eucommia ulmoides health product capable of improving the bone density of astronauts as claimed in claim 1, wherein the preparation method comprises the following steps: extracting the other raw materials except the high-calcium food material, filtering to obtain mixed extract, and mixing with the high-calcium food material.
7. The preparation method of the eucommia ulmoides health product capable of improving the bone density of astronauts as claimed in claim 1, wherein the preparation method comprises the following steps: extracting eucommia ulmoides in the component raw materials to obtain an extracting solution, concentrating, drying and crushing the eucommia ulmoides fine powder, grinding mulberry leaves, ginseng, medlar, cordyceps militaris, black beans, peach kernels, saffron, safflower, angelica sinensis, red paeony roots, radix rehmanniae, achyranthes bidentata, orange peels, fingered citron, allium macrostemon, platycodon grandiflorum, ligusticum wallichii, bitter orange and liquorice, and matching with crushed high-calcium food materials to obtain the eucommia ulmoides extract.
8. The method for preparing eucommia ulmoides oliv health product for increasing bone density of astronauts as claimed in any one of claims 5, 6 or 7, wherein the eucommia ulmoides oliv health product comprises the following steps: during the compatibility, food additives are added, wherein the food additives comprise at least one of acidity regulator, sweetener, preservative, antioxidant, excipient and nutrition enhancer.
9. The method for preparing eucommia ulmoides oliv health product for increasing bone density of astronauts as claimed in any one of claims 5, 6 or 7, wherein the eucommia ulmoides oliv health product comprises the following steps: the preparation formulation of the eucommia health product prepared by compatibility is capsule, tablet, granule, paste, pill or oral liquid.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011199522.0A CN112293748A (en) | 2020-11-02 | 2020-11-02 | Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011199522.0A CN112293748A (en) | 2020-11-02 | 2020-11-02 | Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112293748A true CN112293748A (en) | 2021-02-02 |
Family
ID=74333320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011199522.0A Pending CN112293748A (en) | 2020-11-02 | 2020-11-02 | Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112293748A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114468287A (en) * | 2021-12-31 | 2022-05-13 | 天津市元生泰科技有限公司 | Formula and preparation method of chelated calcium suitable for astronauts |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104621571A (en) * | 2015-03-12 | 2015-05-20 | 宁波高新区苗姑养生科技有限公司 | Strong body-building nutritional health-care food |
CN110313610A (en) * | 2018-03-30 | 2019-10-11 | 北京神飞航天应用技术研究院 | A kind of complex nutrient preparation of suitable spacefarer's body weight control |
CN110664902A (en) * | 2018-07-03 | 2020-01-10 | 王金国 | Chinese medicinal preparation comprising Chinese medicinal materials of yellow color for promoting bone healing and bone metabolism, and its preparation method |
-
2020
- 2020-11-02 CN CN202011199522.0A patent/CN112293748A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104621571A (en) * | 2015-03-12 | 2015-05-20 | 宁波高新区苗姑养生科技有限公司 | Strong body-building nutritional health-care food |
CN110313610A (en) * | 2018-03-30 | 2019-10-11 | 北京神飞航天应用技术研究院 | A kind of complex nutrient preparation of suitable spacefarer's body weight control |
CN110664902A (en) * | 2018-07-03 | 2020-01-10 | 王金国 | Chinese medicinal preparation comprising Chinese medicinal materials of yellow color for promoting bone healing and bone metabolism, and its preparation method |
Non-Patent Citations (1)
Title |
---|
刘振民: "《乳脂及乳脂产品科学与技术》", 31 March 2019, 中国轻工业出版社 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114468287A (en) * | 2021-12-31 | 2022-05-13 | 天津市元生泰科技有限公司 | Formula and preparation method of chelated calcium suitable for astronauts |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100510239B1 (en) | Method for preparing a composition containing corn silk and dietary fibre | |
Kulkarni et al. | Indian gooseberry (Emblica officinalis): Complete pharmacognosy review | |
CN104799146A (en) | Functional nutritional good composition for improving sub-health and preparation method thereof | |
CN104082658A (en) | Instant food for lowering high blood sugar, high blood pressure and high blood lipids and strengthening yang | |
CN104489841A (en) | Maca, ginseng and rhizoma polygonati health drink and preparation method thereof | |
CN112641879A (en) | Traditional Chinese medicine composition for relieving fatigue and preparation method thereof | |
CN107853517B (en) | Traditional Chinese medicine beverage capable of refreshing and resisting fatigue and preparation method thereof | |
CN112546167A (en) | Traditional Chinese medicine composition with spleen invigorating and dampness removing functions and preparation method and application thereof | |
CN101199347A (en) | Pb excluding health care product and its preparation method | |
CN102485268B (en) | Pharmaceutical composition with dispersing food and fortifying spleen as well as its preparation method | |
CN111671020A (en) | Polygonatum sibiricum beverage and preparation method thereof | |
CN105535163A (en) | Traditional Chinese medicine composition for improving flavor quality of livestock and poultry and aquatic products | |
CN108014150A (en) | Application of the natural drug composition in anti anoxia and radiation-resistant medicine or food is prepared | |
KR101771090B1 (en) | Composition for body temperature rise with medicinal herbs classified as a food ingredient and Manufacturing method thereof | |
CN106266112A (en) | A kind of compound Chinese medicinal preparation of invigorating the spleen to arrest diarrhea and preparation method thereof | |
CN112293748A (en) | Eucommia health product capable of improving bone mineral density of astronaut and preparation method thereof | |
CN1209133C (en) | Medicine for preventing and curing rachitis and osteoporosis and method for preparing the same | |
CN106581115B (en) | Composition containing yuankanin and ginseng and application thereof | |
KR20160000695A (en) | Herbal-medicine containing dha for recovering fatigue and enhancing memory, and method of manufacturing the same | |
CN111450218A (en) | Medicine and food for supplementing calcium and energy and adjusting spleen and stomach of children and preparation method thereof | |
KR101783549B1 (en) | Health supplement food containing dha for recovering fatigue, and method of manufacturing the same | |
CN112352894A (en) | Nutritious food prepared from Eucommiae cortex for improving bone density of astronaut, and its application | |
KR20050100890A (en) | Composition comprising the extract of acanthopanax sessiliflorus and green tea for treating or alleviating hangover syndrome | |
KR20090089660A (en) | Composition comprising the extract of lonicera japonica thunb. preventing and treating arthritis | |
KR0137897B1 (en) | Health food containing leaf of eucommia ulmoides oliver |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210202 |
|
RJ01 | Rejection of invention patent application after publication |